nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—renal system—kidney cancer	0.0131	0.173	CbGeAlD
Auranofin—PRDX5—kidney—kidney cancer	0.0127	0.167	CbGeAlD
Auranofin—PRDX5—cortex of kidney—kidney cancer	0.0124	0.163	CbGeAlD
Auranofin—PRDX5—gonad—kidney cancer	0.0118	0.155	CbGeAlD
Auranofin—PRDX5—cardiac atrium—kidney cancer	0.0118	0.155	CbGeAlD
Auranofin—IKBKB—cortex of kidney—kidney cancer	0.00733	0.0963	CbGeAlD
Auranofin—IKBKB—gonad—kidney cancer	0.00698	0.0917	CbGeAlD
Auranofin—Flatulence—Erlotinib—kidney cancer	0.00139	0.00259	CcSEcCtD
Auranofin—Neutropenia—Vincristine—kidney cancer	0.00138	0.00258	CcSEcCtD
Auranofin—Agranulocytosis—Dactinomycin—kidney cancer	0.00138	0.00257	CcSEcCtD
Auranofin—Constipation—Temsirolimus—kidney cancer	0.00137	0.00256	CcSEcCtD
Auranofin—Anaemia—Vinblastine—kidney cancer	0.00136	0.00253	CcSEcCtD
Auranofin—Anaemia—Everolimus—kidney cancer	0.00135	0.00252	CcSEcCtD
Auranofin—Weight decreased—Vincristine—kidney cancer	0.00134	0.0025	CcSEcCtD
Auranofin—Angioedema—Everolimus—kidney cancer	0.00133	0.00249	CcSEcCtD
Auranofin—Pancytopenia—Gemcitabine—kidney cancer	0.00133	0.00249	CcSEcCtD
Auranofin—Dyspepsia—Pazopanib—kidney cancer	0.00133	0.00248	CcSEcCtD
Auranofin—Neutropenia—Gemcitabine—kidney cancer	0.00131	0.00245	CcSEcCtD
Auranofin—Leukopenia—Vinblastine—kidney cancer	0.00131	0.00245	CcSEcCtD
Auranofin—Decreased appetite—Pazopanib—kidney cancer	0.00131	0.00245	CcSEcCtD
Auranofin—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00131	0.00244	CcSEcCtD
Auranofin—Eye disorder—Sunitinib—kidney cancer	0.00131	0.00244	CcSEcCtD
Auranofin—Leukopenia—Everolimus—kidney cancer	0.00131	0.00244	CcSEcCtD
Auranofin—Neuropathy peripheral—Vincristine—kidney cancer	0.00129	0.00241	CcSEcCtD
Auranofin—Stomatitis—Vincristine—kidney cancer	0.00129	0.0024	CcSEcCtD
Auranofin—Alopecia—Sorafenib—kidney cancer	0.00129	0.0024	CcSEcCtD
Auranofin—Abdominal pain—Temsirolimus—kidney cancer	0.00127	0.00236	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—kidney cancer	0.00126	0.00236	CcSEcCtD
Auranofin—Dysgeusia—Sorafenib—kidney cancer	0.00124	0.00231	CcSEcCtD
Auranofin—Alopecia—Sunitinib—kidney cancer	0.00124	0.00231	CcSEcCtD
Auranofin—Gastrointestinal pain—Pazopanib—kidney cancer	0.00123	0.0023	CcSEcCtD
Auranofin—Neuropathy peripheral—Gemcitabine—kidney cancer	0.00123	0.00229	CcSEcCtD
Auranofin—Stomatitis—Gemcitabine—kidney cancer	0.00122	0.00228	CcSEcCtD
Auranofin—Flatulence—Sunitinib—kidney cancer	0.0012	0.00224	CcSEcCtD
Auranofin—Dysgeusia—Sunitinib—kidney cancer	0.00119	0.00223	CcSEcCtD
Auranofin—Haematuria—Gemcitabine—kidney cancer	0.00119	0.00223	CcSEcCtD
Auranofin—Abdominal pain—Pazopanib—kidney cancer	0.00119	0.00223	CcSEcCtD
Auranofin—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00118	0.00221	CcSEcCtD
Auranofin—Dysphagia—Paclitaxel—kidney cancer	0.00118	0.00219	CcSEcCtD
Auranofin—Alopecia—Dactinomycin—kidney cancer	0.00117	0.00219	CcSEcCtD
Auranofin—Anaemia—Sorafenib—kidney cancer	0.00117	0.00218	CcSEcCtD
Auranofin—Thrombocytopenia—Vinblastine—kidney cancer	0.00117	0.00218	CcSEcCtD
Auranofin—Agranulocytosis—Gemcitabine—kidney cancer	0.00117	0.00218	CcSEcCtD
Auranofin—Thrombocytopenia—Everolimus—kidney cancer	0.00117	0.00218	CcSEcCtD
Auranofin—Angioedema—Sorafenib—kidney cancer	0.00116	0.00216	CcSEcCtD
Auranofin—Anorexia—Vinblastine—kidney cancer	0.00114	0.00213	CcSEcCtD
Auranofin—Anorexia—Everolimus—kidney cancer	0.00114	0.00212	CcSEcCtD
Auranofin—Leukopenia—Sorafenib—kidney cancer	0.00113	0.00212	CcSEcCtD
Auranofin—Pruritus—Temsirolimus—kidney cancer	0.00113	0.00211	CcSEcCtD
Auranofin—Anaemia—Sunitinib—kidney cancer	0.00113	0.0021	CcSEcCtD
Auranofin—Thrombocytopenia—Erlotinib—kidney cancer	0.00113	0.0021	CcSEcCtD
Auranofin—Pancytopenia—Paclitaxel—kidney cancer	0.00112	0.00208	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.00112	0.00208	CcSEcCtD
Auranofin—Angioedema—Sunitinib—kidney cancer	0.00111	0.00208	CcSEcCtD
Auranofin—Neutropenia—Paclitaxel—kidney cancer	0.0011	0.00205	CcSEcCtD
Auranofin—Diarrhoea—Temsirolimus—kidney cancer	0.0011	0.00204	CcSEcCtD
Auranofin—Anorexia—Erlotinib—kidney cancer	0.0011	0.00204	CcSEcCtD
Auranofin—Leukopenia—Sunitinib—kidney cancer	0.00109	0.00204	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—kidney cancer	0.00108	0.00201	CcSEcCtD
Auranofin—Pruritus—Pazopanib—kidney cancer	0.00107	0.00199	CcSEcCtD
Auranofin—Anaemia—Dactinomycin—kidney cancer	0.00107	0.00199	CcSEcCtD
Auranofin—Weight decreased—Paclitaxel—kidney cancer	0.00106	0.00198	CcSEcCtD
Auranofin—Dyspepsia—Everolimus—kidney cancer	0.00105	0.00196	CcSEcCtD
Auranofin—Alopecia—Vincristine—kidney cancer	0.00105	0.00195	CcSEcCtD
Auranofin—Decreased appetite—Vinblastine—kidney cancer	0.00104	0.00194	CcSEcCtD
Auranofin—Decreased appetite—Everolimus—kidney cancer	0.00104	0.00193	CcSEcCtD
Auranofin—Leukopenia—Dactinomycin—kidney cancer	0.00103	0.00193	CcSEcCtD
Auranofin—Diarrhoea—Pazopanib—kidney cancer	0.00103	0.00193	CcSEcCtD
Auranofin—Neuropathy peripheral—Paclitaxel—kidney cancer	0.00103	0.00192	CcSEcCtD
Auranofin—Constipation—Vinblastine—kidney cancer	0.00102	0.00191	CcSEcCtD
Auranofin—Stomatitis—Paclitaxel—kidney cancer	0.00102	0.00191	CcSEcCtD
Auranofin—Conjunctivitis—Paclitaxel—kidney cancer	0.00102	0.0019	CcSEcCtD
Auranofin—Constipation—Everolimus—kidney cancer	0.00102	0.0019	CcSEcCtD
Auranofin—Vomiting—Temsirolimus—kidney cancer	0.00102	0.0019	CcSEcCtD
Auranofin—Thrombocytopenia—Sorafenib—kidney cancer	0.00101	0.00189	CcSEcCtD
Auranofin—Dyspepsia—Erlotinib—kidney cancer	0.00101	0.00189	CcSEcCtD
Auranofin—Rash—Temsirolimus—kidney cancer	0.00101	0.00188	CcSEcCtD
Auranofin—Dermatitis—Temsirolimus—kidney cancer	0.00101	0.00188	CcSEcCtD
Auranofin—Haematuria—Paclitaxel—kidney cancer	0.001	0.00186	CcSEcCtD
Auranofin—Decreased appetite—Erlotinib—kidney cancer	0.001	0.00186	CcSEcCtD
Auranofin—Alopecia—Gemcitabine—kidney cancer	0.000994	0.00185	CcSEcCtD
Auranofin—Anorexia—Sorafenib—kidney cancer	0.000986	0.00184	CcSEcCtD
Auranofin—Constipation—Erlotinib—kidney cancer	0.000983	0.00183	CcSEcCtD
Auranofin—Gastrointestinal pain—Vinblastine—kidney cancer	0.000978	0.00182	CcSEcCtD
Auranofin—Thrombocytopenia—Sunitinib—kidney cancer	0.000975	0.00182	CcSEcCtD
Auranofin—Gastrointestinal pain—Everolimus—kidney cancer	0.000975	0.00182	CcSEcCtD
Auranofin—Melaena—Doxorubicin—kidney cancer	0.000969	0.00181	CcSEcCtD
Auranofin—Dysphagia—Capecitabine—kidney cancer	0.000965	0.0018	CcSEcCtD
Auranofin—Vomiting—Pazopanib—kidney cancer	0.00096	0.00179	CcSEcCtD
Auranofin—Anaemia—Vincristine—kidney cancer	0.000954	0.00178	CcSEcCtD
Auranofin—Rash—Pazopanib—kidney cancer	0.000952	0.00177	CcSEcCtD
Auranofin—Nausea—Temsirolimus—kidney cancer	0.000952	0.00177	CcSEcCtD
Auranofin—Dermatitis—Pazopanib—kidney cancer	0.000951	0.00177	CcSEcCtD
Auranofin—Anorexia—Sunitinib—kidney cancer	0.000949	0.00177	CcSEcCtD
Auranofin—Abdominal pain—Vinblastine—kidney cancer	0.000946	0.00176	CcSEcCtD
Auranofin—Abdominal pain—Everolimus—kidney cancer	0.000942	0.00176	CcSEcCtD
Auranofin—Gastrointestinal pain—Erlotinib—kidney cancer	0.00094	0.00175	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—kidney cancer	0.000931	0.00174	CcSEcCtD
Auranofin—Leukopenia—Vincristine—kidney cancer	0.000924	0.00172	CcSEcCtD
Auranofin—Thrombocytopenia—Dactinomycin—kidney cancer	0.000923	0.00172	CcSEcCtD
Auranofin—Pancytopenia—Capecitabine—kidney cancer	0.000917	0.00171	CcSEcCtD
Auranofin—Dyspepsia—Sorafenib—kidney cancer	0.000911	0.0017	CcSEcCtD
Auranofin—Abdominal pain—Erlotinib—kidney cancer	0.000909	0.0017	CcSEcCtD
Auranofin—Visual impairment—Paclitaxel—kidney cancer	0.000907	0.00169	CcSEcCtD
Auranofin—Anaemia—Gemcitabine—kidney cancer	0.000905	0.00169	CcSEcCtD
Auranofin—Neutropenia—Capecitabine—kidney cancer	0.000903	0.00168	CcSEcCtD
Auranofin—Decreased appetite—Sorafenib—kidney cancer	0.000899	0.00168	CcSEcCtD
Auranofin—Anorexia—Dactinomycin—kidney cancer	0.000898	0.00168	CcSEcCtD
Auranofin—Nausea—Pazopanib—kidney cancer	0.000897	0.00167	CcSEcCtD
Auranofin—Constipation—Sorafenib—kidney cancer	0.000885	0.00165	CcSEcCtD
Auranofin—Eye disorder—Paclitaxel—kidney cancer	0.00088	0.00164	CcSEcCtD
Auranofin—Dyspepsia—Sunitinib—kidney cancer	0.000876	0.00163	CcSEcCtD
Auranofin—Leukopenia—Gemcitabine—kidney cancer	0.000876	0.00163	CcSEcCtD
Auranofin—Weight decreased—Capecitabine—kidney cancer	0.000873	0.00163	CcSEcCtD
Auranofin—Decreased appetite—Sunitinib—kidney cancer	0.000865	0.00161	CcSEcCtD
Auranofin—Constipation—Sunitinib—kidney cancer	0.000851	0.00159	CcSEcCtD
Auranofin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000846	0.00158	CcSEcCtD
Auranofin—Neuropathy peripheral—Capecitabine—kidney cancer	0.000844	0.00157	CcSEcCtD
Auranofin—Pruritus—Everolimus—kidney cancer	0.000843	0.00157	CcSEcCtD
Auranofin—Stomatitis—Capecitabine—kidney cancer	0.000839	0.00156	CcSEcCtD
Auranofin—Jaundice—Capecitabine—kidney cancer	0.000839	0.00156	CcSEcCtD
Auranofin—Conjunctivitis—Capecitabine—kidney cancer	0.000837	0.00156	CcSEcCtD
Auranofin—Alopecia—Paclitaxel—kidney cancer	0.000832	0.00155	CcSEcCtD
Auranofin—Thrombocytopenia—Vincristine—kidney cancer	0.000824	0.00154	CcSEcCtD
Auranofin—Urticaria—Sorafenib—kidney cancer	0.000822	0.00153	CcSEcCtD
Auranofin—Haematuria—Capecitabine—kidney cancer	0.000821	0.00153	CcSEcCtD
Auranofin—Decreased appetite—Dactinomycin—kidney cancer	0.000819	0.00153	CcSEcCtD
Auranofin—Diarrhoea—Vinblastine—kidney cancer	0.000819	0.00153	CcSEcCtD
Auranofin—Abdominal pain—Sorafenib—kidney cancer	0.000818	0.00153	CcSEcCtD
Auranofin—Diarrhoea—Everolimus—kidney cancer	0.000816	0.00152	CcSEcCtD
Auranofin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000814	0.00152	CcSEcCtD
Auranofin—Pruritus—Erlotinib—kidney cancer	0.000814	0.00152	CcSEcCtD
Auranofin—Flatulence—Paclitaxel—kidney cancer	0.000808	0.00151	CcSEcCtD
Auranofin—Agranulocytosis—Capecitabine—kidney cancer	0.000803	0.0015	CcSEcCtD
Auranofin—Anorexia—Vincristine—kidney cancer	0.000803	0.0015	CcSEcCtD
Auranofin—Dysgeusia—Paclitaxel—kidney cancer	0.000803	0.0015	CcSEcCtD
Auranofin—Abdominal pain—Sunitinib—kidney cancer	0.000787	0.00147	CcSEcCtD
Auranofin—Diarrhoea—Erlotinib—kidney cancer	0.000787	0.00147	CcSEcCtD
Auranofin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000782	0.00146	CcSEcCtD
Auranofin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000771	0.00144	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000763	0.00142	CcSEcCtD
Auranofin—Anorexia—Gemcitabine—kidney cancer	0.000761	0.00142	CcSEcCtD
Auranofin—Vomiting—Vinblastine—kidney cancer	0.000761	0.00142	CcSEcCtD
Auranofin—Vomiting—Everolimus—kidney cancer	0.000758	0.00141	CcSEcCtD
Auranofin—Anaemia—Paclitaxel—kidney cancer	0.000757	0.00141	CcSEcCtD
Auranofin—Rash—Everolimus—kidney cancer	0.000752	0.0014	CcSEcCtD
Auranofin—Dermatitis—Everolimus—kidney cancer	0.000751	0.0014	CcSEcCtD
Auranofin—Angioedema—Paclitaxel—kidney cancer	0.000749	0.0014	CcSEcCtD
Auranofin—Abdominal pain—Dactinomycin—kidney cancer	0.000745	0.00139	CcSEcCtD
Auranofin—Visual impairment—Capecitabine—kidney cancer	0.000745	0.00139	CcSEcCtD
Auranofin—Leukopenia—Paclitaxel—kidney cancer	0.000734	0.00137	CcSEcCtD
Auranofin—Decreased appetite—Vincristine—kidney cancer	0.000732	0.00136	CcSEcCtD
Auranofin—Pruritus—Sorafenib—kidney cancer	0.000732	0.00136	CcSEcCtD
Auranofin—Vomiting—Erlotinib—kidney cancer	0.000731	0.00136	CcSEcCtD
Auranofin—Rash—Erlotinib—kidney cancer	0.000725	0.00135	CcSEcCtD
Auranofin—Dermatitis—Erlotinib—kidney cancer	0.000724	0.00135	CcSEcCtD
Auranofin—Eye disorder—Capecitabine—kidney cancer	0.000722	0.00135	CcSEcCtD
Auranofin—Constipation—Vincristine—kidney cancer	0.00072	0.00134	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.00072	0.00134	CcSEcCtD
Auranofin—Nausea—Vinblastine—kidney cancer	0.000711	0.00133	CcSEcCtD
Auranofin—Nausea—Everolimus—kidney cancer	0.000708	0.00132	CcSEcCtD
Auranofin—Diarrhoea—Sorafenib—kidney cancer	0.000708	0.00132	CcSEcCtD
Auranofin—Pruritus—Sunitinib—kidney cancer	0.000704	0.00131	CcSEcCtD
Auranofin—Decreased appetite—Gemcitabine—kidney cancer	0.000694	0.00129	CcSEcCtD
Auranofin—Gastrointestinal pain—Vincristine—kidney cancer	0.000689	0.00128	CcSEcCtD
Auranofin—Constipation—Gemcitabine—kidney cancer	0.000683	0.00127	CcSEcCtD
Auranofin—Nausea—Erlotinib—kidney cancer	0.000683	0.00127	CcSEcCtD
Auranofin—Alopecia—Capecitabine—kidney cancer	0.000683	0.00127	CcSEcCtD
Auranofin—Diarrhoea—Sunitinib—kidney cancer	0.000681	0.00127	CcSEcCtD
Auranofin—Abdominal pain—Vincristine—kidney cancer	0.000666	0.00124	CcSEcCtD
Auranofin—Flatulence—Capecitabine—kidney cancer	0.000663	0.00124	CcSEcCtD
Auranofin—Dysgeusia—Capecitabine—kidney cancer	0.000659	0.00123	CcSEcCtD
Auranofin—Vomiting—Sorafenib—kidney cancer	0.000658	0.00123	CcSEcCtD
Auranofin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000655	0.00122	CcSEcCtD
Auranofin—Rash—Sorafenib—kidney cancer	0.000652	0.00122	CcSEcCtD
Auranofin—Dermatitis—Sorafenib—kidney cancer	0.000652	0.00122	CcSEcCtD
Auranofin—Diarrhoea—Dactinomycin—kidney cancer	0.000645	0.0012	CcSEcCtD
Auranofin—Anorexia—Paclitaxel—kidney cancer	0.000638	0.00119	CcSEcCtD
Auranofin—Vomiting—Sunitinib—kidney cancer	0.000633	0.00118	CcSEcCtD
Auranofin—Rash—Sunitinib—kidney cancer	0.000628	0.00117	CcSEcCtD
Auranofin—Dermatitis—Sunitinib—kidney cancer	0.000627	0.00117	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—kidney cancer	0.000622	0.00116	CcSEcCtD
Auranofin—Anaemia—Capecitabine—kidney cancer	0.000622	0.00116	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—kidney cancer	0.000616	0.00115	CcSEcCtD
Auranofin—Nausea—Sorafenib—kidney cancer	0.000615	0.00115	CcSEcCtD
Auranofin—Leukopenia—Capecitabine—kidney cancer	0.000602	0.00112	CcSEcCtD
Auranofin—Vomiting—Dactinomycin—kidney cancer	0.000599	0.00112	CcSEcCtD
Auranofin—Rash—Dactinomycin—kidney cancer	0.000594	0.00111	CcSEcCtD
Auranofin—Nausea—Sunitinib—kidney cancer	0.000591	0.0011	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—kidney cancer	0.000591	0.0011	CcSEcCtD
Auranofin—Dyspepsia—Paclitaxel—kidney cancer	0.000589	0.0011	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—kidney cancer	0.000582	0.00108	CcSEcCtD
Auranofin—Decreased appetite—Paclitaxel—kidney cancer	0.000581	0.00108	CcSEcCtD
Auranofin—Diarrhoea—Vincristine—kidney cancer	0.000576	0.00107	CcSEcCtD
Auranofin—Constipation—Paclitaxel—kidney cancer	0.000572	0.00107	CcSEcCtD
Auranofin—Pruritus—Gemcitabine—kidney cancer	0.000565	0.00105	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—kidney cancer	0.000563	0.00105	CcSEcCtD
Auranofin—Nausea—Dactinomycin—kidney cancer	0.00056	0.00104	CcSEcCtD
Auranofin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000547	0.00102	CcSEcCtD
Auranofin—Diarrhoea—Gemcitabine—kidney cancer	0.000547	0.00102	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000544	0.00101	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—kidney cancer	0.000541	0.00101	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—kidney cancer	0.000541	0.00101	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—kidney cancer	0.000539	0.00101	CcSEcCtD
Auranofin—Thrombocytopenia—Capecitabine—kidney cancer	0.000537	0.001	CcSEcCtD
Auranofin—Vomiting—Vincristine—kidney cancer	0.000535	0.000998	CcSEcCtD
Auranofin—Urticaria—Paclitaxel—kidney cancer	0.000531	0.000991	CcSEcCtD
Auranofin—Rash—Vincristine—kidney cancer	0.000531	0.00099	CcSEcCtD
Auranofin—Dermatitis—Vincristine—kidney cancer	0.00053	0.000989	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—kidney cancer	0.000529	0.000986	CcSEcCtD
Auranofin—Abdominal pain—Paclitaxel—kidney cancer	0.000529	0.000986	CcSEcCtD
Auranofin—Anorexia—Capecitabine—kidney cancer	0.000523	0.000976	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—kidney cancer	0.000518	0.000965	CcSEcCtD
Auranofin—Vomiting—Gemcitabine—kidney cancer	0.000508	0.000947	CcSEcCtD
Auranofin—Rash—Gemcitabine—kidney cancer	0.000504	0.000939	CcSEcCtD
Auranofin—Dermatitis—Gemcitabine—kidney cancer	0.000503	0.000938	CcSEcCtD
Auranofin—Nausea—Vincristine—kidney cancer	0.0005	0.000933	CcSEcCtD
Auranofin—Dyspepsia—Capecitabine—kidney cancer	0.000483	0.000901	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—kidney cancer	0.00048	0.000895	CcSEcCtD
Auranofin—Decreased appetite—Capecitabine—kidney cancer	0.000477	0.00089	CcSEcCtD
Auranofin—Nausea—Gemcitabine—kidney cancer	0.000475	0.000885	CcSEcCtD
Auranofin—Pruritus—Paclitaxel—kidney cancer	0.000473	0.000882	CcSEcCtD
Auranofin—Constipation—Capecitabine—kidney cancer	0.000469	0.000875	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—kidney cancer	0.000465	0.000868	CcSEcCtD
Auranofin—Diarrhoea—Paclitaxel—kidney cancer	0.000458	0.000853	CcSEcCtD
Auranofin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000449	0.000837	CcSEcCtD
Auranofin—Alopecia—Doxorubicin—kidney cancer	0.00044	0.000821	CcSEcCtD
Auranofin—Urticaria—Capecitabine—kidney cancer	0.000436	0.000813	CcSEcCtD
Auranofin—Abdominal pain—Capecitabine—kidney cancer	0.000434	0.000809	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—kidney cancer	0.000427	0.000797	CcSEcCtD
Auranofin—Vomiting—Paclitaxel—kidney cancer	0.000425	0.000793	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—kidney cancer	0.000425	0.000792	CcSEcCtD
Auranofin—Rash—Paclitaxel—kidney cancer	0.000422	0.000786	CcSEcCtD
Auranofin—Dermatitis—Paclitaxel—kidney cancer	0.000421	0.000786	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—kidney cancer	0.000401	0.000747	CcSEcCtD
Auranofin—Nausea—Paclitaxel—kidney cancer	0.000397	0.000741	CcSEcCtD
Auranofin—Pruritus—Capecitabine—kidney cancer	0.000388	0.000724	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—kidney cancer	0.000388	0.000724	CcSEcCtD
Auranofin—Diarrhoea—Capecitabine—kidney cancer	0.000376	0.0007	CcSEcCtD
Auranofin—Vomiting—Capecitabine—kidney cancer	0.000349	0.000651	CcSEcCtD
Auranofin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000346	0.000646	CcSEcCtD
Auranofin—Rash—Capecitabine—kidney cancer	0.000346	0.000645	CcSEcCtD
Auranofin—Dermatitis—Capecitabine—kidney cancer	0.000346	0.000645	CcSEcCtD
Auranofin—Anorexia—Doxorubicin—kidney cancer	0.000337	0.000629	CcSEcCtD
Auranofin—Nausea—Capecitabine—kidney cancer	0.000326	0.000608	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—kidney cancer	0.000311	0.000581	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—kidney cancer	0.000308	0.000573	CcSEcCtD
Auranofin—Constipation—Doxorubicin—kidney cancer	0.000303	0.000564	CcSEcCtD
Auranofin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000289	0.000539	CcSEcCtD
Auranofin—Urticaria—Doxorubicin—kidney cancer	0.000281	0.000524	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—kidney cancer	0.00028	0.000522	CcSEcCtD
Auranofin—Pruritus—Doxorubicin—kidney cancer	0.00025	0.000467	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—kidney cancer	0.000242	0.000451	CcSEcCtD
Auranofin—Vomiting—Doxorubicin—kidney cancer	0.000225	0.000419	CcSEcCtD
Auranofin—Rash—Doxorubicin—kidney cancer	0.000223	0.000416	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—kidney cancer	0.000223	0.000416	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—MAPK3—kidney cancer	0.000212	0.000547	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—KRAS—kidney cancer	0.00021	0.000542	CbGpPWpGaD
Auranofin—Nausea—Doxorubicin—kidney cancer	0.00021	0.000392	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—kidney cancer	0.00021	0.000541	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CTSB—kidney cancer	0.000209	0.000539	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CTSD—kidney cancer	0.000208	0.000536	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—JUN—kidney cancer	0.000207	0.000533	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—PIK3CA—kidney cancer	0.000202	0.000521	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—MAPK1—kidney cancer	0.000202	0.000521	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PSMD7—kidney cancer	0.000202	0.000521	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—RELA—kidney cancer	0.000201	0.000519	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—RELA—kidney cancer	0.000201	0.000519	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1B—kidney cancer	0.0002	0.000517	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—ERBB2—kidney cancer	0.0002	0.000516	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PTEN—kidney cancer	0.0002	0.000516	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TCEB2—kidney cancer	0.000199	0.000513	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TCEB1—kidney cancer	0.000199	0.000513	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—JUN—kidney cancer	0.000199	0.000513	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—MTOR—kidney cancer	0.000197	0.000509	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000197	0.000508	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000195	0.000504	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AMER1—kidney cancer	0.000193	0.000499	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PTEN—kidney cancer	0.000193	0.000498	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—PIK3CA—kidney cancer	0.000193	0.000498	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—MAPK3—kidney cancer	0.000191	0.000493	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—JUN—kidney cancer	0.000191	0.000492	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.00019	0.00049	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KEAP1—kidney cancer	0.00019	0.00049	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KIT—kidney cancer	0.00019	0.000489	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00019	0.000489	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00019	0.000489	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00019	0.000489	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—MAPK3—kidney cancer	0.000189	0.000487	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PAK1—kidney cancer	0.000189	0.000487	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—MAPK3—kidney cancer	0.000186	0.000479	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CDKN1B—kidney cancer	0.000185	0.000478	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PTEN—kidney cancer	0.000184	0.000476	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFNA1—kidney cancer	0.000184	0.000475	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—MAPK1—kidney cancer	0.000182	0.000469	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KCNMA1—kidney cancer	0.000182	0.000468	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PAK1—kidney cancer	0.000181	0.000467	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—MAPK1—kidney cancer	0.00018	0.000464	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—BRAF—kidney cancer	0.000178	0.00046	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—MAPK1—kidney cancer	0.000177	0.000456	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.000176	0.000453	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP2—kidney cancer	0.000172	0.000443	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFNA2—kidney cancer	0.000171	0.000442	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MAPK3—kidney cancer	0.000171	0.000441	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PTEN—kidney cancer	0.000171	0.00044	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACY1—kidney cancer	0.000169	0.000436	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—kidney cancer	0.000166	0.000429	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD34—kidney cancer	0.000165	0.000425	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK3—kidney cancer	0.000164	0.000424	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MAPK1—kidney cancer	0.000162	0.000419	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GPC3—kidney cancer	0.000162	0.000418	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CER1—kidney cancer	0.000162	0.000418	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—kidney cancer	0.00016	0.000412	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GRB7—kidney cancer	0.000158	0.000409	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	0.000158	0.000408	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CA—kidney cancer	0.000158	0.000407	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK3—kidney cancer	0.000158	0.000406	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CARD11—kidney cancer	0.000157	0.000405	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK1—kidney cancer	0.000156	0.000403	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—RAF1—kidney cancer	0.000151	0.000391	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—RELA—kidney cancer	0.000151	0.000389	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK1—kidney cancer	0.00015	0.000387	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RAF1—kidney cancer	0.000149	0.000384	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—kidney cancer	0.000148	0.000383	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RELA—kidney cancer	0.000148	0.000382	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—kidney cancer	0.000148	0.000381	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB2—kidney cancer	0.000147	0.00038	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ITPR2—kidney cancer	0.000147	0.00038	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—kidney cancer	0.000146	0.000378	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ITPR2—kidney cancer	0.000146	0.000377	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MTOR—kidney cancer	0.000145	0.000375	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000144	0.000372	CbGpPWpGaD
Auranofin—ALB—Metabolism—PDHB—kidney cancer	0.000144	0.000371	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—kidney cancer	0.000142	0.000365	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PIK3CA—kidney cancer	0.000141	0.000364	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—kidney cancer	0.000138	0.000357	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SFRP2—kidney cancer	0.000138	0.000356	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1B—kidney cancer	0.000136	0.000352	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—kidney cancer	0.000136	0.000351	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—kidney cancer	0.000136	0.00035	CbGpPWpGaD
Auranofin—ALB—Metabolism—CCBL1—kidney cancer	0.000135	0.000349	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—kidney cancer	0.000131	0.000338	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—kidney cancer	0.000131	0.000338	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—kidney cancer	0.00013	0.000336	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSB—kidney cancer	0.000127	0.000327	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSD—kidney cancer	0.000126	0.000325	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PTEN—kidney cancer	0.000126	0.000324	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TSC2—kidney cancer	0.000122	0.000316	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PSMD7—kidney cancer	0.000122	0.000316	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000122	0.000315	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PIK3CA—kidney cancer	0.00012	0.00031	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—TSC2—kidney cancer	0.000118	0.000303	CbGpPWpGaD
Auranofin—ALB—Metabolism—GLIPR1—kidney cancer	0.000117	0.000302	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPAT—kidney cancer	0.000117	0.000302	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000116	0.000299	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000115	0.000296	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKAP13—kidney cancer	0.000111	0.000287	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP2—kidney cancer	0.000111	0.000287	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PAK1—kidney cancer	0.00011	0.000284	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—MAPK3—kidney cancer	0.000109	0.000282	CbGpPWpGaD
Auranofin—ALB—Metabolism—FH—kidney cancer	0.000109	0.000281	CbGpPWpGaD
Auranofin—ALB—Metabolism—APRT—kidney cancer	0.000109	0.000281	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KIT—kidney cancer	0.000108	0.000279	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNA1—kidney cancer	0.000108	0.000279	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK3—kidney cancer	0.000107	0.000277	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNA1—kidney cancer	0.000107	0.000277	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000106	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KIT—kidney cancer	0.000104	0.000268	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—MAPK1—kidney cancer	0.000104	0.000268	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGR1—kidney cancer	0.000103	0.000265	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPC3—kidney cancer	0.000102	0.000264	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK1—kidney cancer	0.000102	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRB7—kidney cancer	0.000102	0.000262	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNA2—kidney cancer	0.000101	0.000259	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.0001	0.000258	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNA2—kidney cancer	9.98e-05	0.000257	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA2—kidney cancer	9.97e-05	0.000257	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—kidney cancer	9.81e-05	0.000253	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALAD—kidney cancer	9.71e-05	0.000251	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	9.67e-05	0.000249	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.66e-05	0.000249	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—kidney cancer	9.64e-05	0.000249	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—kidney cancer	9.56e-05	0.000247	CbGpPWpGaD
Auranofin—ALB—Metabolism—ST3GAL2—kidney cancer	9.48e-05	0.000245	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ITPR2—kidney cancer	9.44e-05	0.000244	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDH1A1—kidney cancer	9.26e-05	0.000239	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF2—kidney cancer	9.06e-05	0.000234	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—kidney cancer	9.01e-05	0.000232	CbGpPWpGaD
Auranofin—ALB—Metabolism—PGK1—kidney cancer	8.88e-05	0.000229	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC5A3—kidney cancer	8.88e-05	0.000229	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—kidney cancer	8.86e-05	0.000229	CbGpPWpGaD
Auranofin—ALB—Metabolism—LDHB—kidney cancer	8.71e-05	0.000225	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	8.67e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNA1—kidney cancer	8.56e-05	0.000221	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HSPB1—kidney cancer	8.51e-05	0.00022	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EIF4EBP1—kidney cancer	8.51e-05	0.00022	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RAF1—kidney cancer	8.49e-05	0.000219	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RELA—kidney cancer	8.45e-05	0.000218	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—kidney cancer	8.4e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—kidney cancer	8.39e-05	0.000216	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MTOR—kidney cancer	8.29e-05	0.000214	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—kidney cancer	8.27e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RAF1—kidney cancer	8.15e-05	0.00021	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RELA—kidney cancer	8.12e-05	0.000209	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—kidney cancer	8.07e-05	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MTOR—kidney cancer	7.96e-05	0.000205	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—kidney cancer	7.94e-05	0.000205	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TSC1—kidney cancer	7.91e-05	0.000204	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSMD7—kidney cancer	7.91e-05	0.000204	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ANXA1—kidney cancer	7.91e-05	0.000204	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1B—kidney cancer	7.78e-05	0.000201	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FLT1—kidney cancer	7.67e-05	0.000198	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.63e-05	0.000197	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA9—kidney cancer	7.55e-05	0.000195	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1B—kidney cancer	7.47e-05	0.000193	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—JUN—kidney cancer	7.41e-05	0.000191	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.38e-05	0.00019	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	7.37e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—kidney cancer	7.35e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTEN—kidney cancer	7.16e-05	0.000185	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TSC2—kidney cancer	7.13e-05	0.000184	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PAK1—kidney cancer	7.11e-05	0.000183	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUNB—kidney cancer	7.11e-05	0.000183	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	6.97e-05	0.00018	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTEN—kidney cancer	6.88e-05	0.000177	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	6.63e-05	0.000171	CbGpPWpGaD
Auranofin—ALB—Metabolism—CRABP1—kidney cancer	6.42e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KIT—kidney cancer	6.3e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK3—kidney cancer	6.12e-05	0.000158	CbGpPWpGaD
Auranofin—ALB—Metabolism—ITPR2—kidney cancer	5.97e-05	0.000154	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK1—kidney cancer	5.82e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF2—kidney cancer	5.81e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—kidney cancer	5.8e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN2B—kidney cancer	5.78e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	5.75e-05	0.000148	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1R—kidney cancer	5.62e-05	0.000145	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.5e-05	0.000142	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—kidney cancer	5.5e-05	0.000142	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACHE—kidney cancer	5.44e-05	0.00014	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTT1—kidney cancer	5.44e-05	0.00014	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—kidney cancer	5.28e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Metabolism—SCARB1—kidney cancer	5.15e-05	0.000133	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS1—kidney cancer	5.1e-05	0.000132	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—kidney cancer	5.05e-05	0.00013	CbGpPWpGaD
Auranofin—ALB—Metabolism—PSMD7—kidney cancer	5e-05	0.000129	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RAF1—kidney cancer	4.98e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RAF1—kidney cancer	4.94e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RELA—kidney cancer	4.92e-05	0.000127	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—kidney cancer	4.89e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—kidney cancer	4.85e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MTOR—kidney cancer	4.83e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—kidney cancer	4.82e-05	0.000124	CbGpPWpGaD
Auranofin—ALB—Metabolism—BCHE—kidney cancer	4.74e-05	0.000122	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC5A5—kidney cancer	4.68e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HIF1A—kidney cancer	4.62e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TSC2—kidney cancer	4.61e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1B—kidney cancer	4.53e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC2A1—kidney cancer	4.52e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—kidney cancer	4.47e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—kidney cancer	4.43e-05	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KDR—kidney cancer	4.42e-05	0.000114	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.39e-05	0.000113	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	4.31e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JUN—kidney cancer	4.31e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—kidney cancer	4.28e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTEN—kidney cancer	4.17e-05	0.000108	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APC—kidney cancer	4.07e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KIT—kidney cancer	4.07e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—POMC—kidney cancer	3.88e-05	0.0001	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BRAF—kidney cancer	3.83e-05	9.88e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.83e-05	9.88e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—kidney cancer	3.8e-05	9.8e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—kidney cancer	3.77e-05	9.73e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK3—kidney cancer	3.59e-05	9.27e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—kidney cancer	3.57e-05	9.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK3—kidney cancer	3.56e-05	9.2e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—kidney cancer	3.47e-05	8.95e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK1—kidney cancer	3.42e-05	8.82e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK1—kidney cancer	3.39e-05	8.75e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1A1—kidney cancer	3.29e-05	8.48e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—kidney cancer	3.23e-05	8.33e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—kidney cancer	3.2e-05	8.26e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAF1—kidney cancer	3.2e-05	8.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RELA—kidney cancer	3.18e-05	8.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—kidney cancer	3.16e-05	8.16e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTOR—kidney cancer	3.12e-05	8.05e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—kidney cancer	2.97e-05	7.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—kidney cancer	2.94e-05	7.59e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1B—kidney cancer	2.93e-05	7.56e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—kidney cancer	2.87e-05	7.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—kidney cancer	2.87e-05	7.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—kidney cancer	2.79e-05	7.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUN—kidney cancer	2.79e-05	7.19e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—kidney cancer	2.77e-05	7.14e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.7e-05	6.97e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTEN—kidney cancer	2.7e-05	6.96e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—POMC—kidney cancer	2.45e-05	6.32e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—kidney cancer	2.44e-05	6.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK3—kidney cancer	2.3e-05	5.95e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—kidney cancer	2.24e-05	5.78e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK1—kidney cancer	2.19e-05	5.66e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—kidney cancer	2.07e-05	5.34e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—kidney cancer	1.95e-05	5.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—kidney cancer	1.9e-05	4.91e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—kidney cancer	1.84e-05	4.75e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTEN—kidney cancer	1.7e-05	4.4e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—kidney cancer	1.2e-05	3.1e-05	CbGpPWpGaD
